Maclennan CA, Martin LB, Micoli F. Vaccines against invasive Salmonella disease：Current status and future directions[J]. Human Vaccines & Immunotherapeutics, 2014, 10(6)：1478-1493.
[2]
Labrie SJ, Samson JE, Moineau S, et al. Bacteriophage resistance mechanisms[J]. Nature Reviews Microbiology, 2010, 8(5)：317-327.
Shanta, D Surojit, D Utpala M, et al. Antimicrobial resistance, virulence profiles and molecular subtypes of Salmonella enterica serovars typhi and paratyphi A blood isolates from Kolkata, India during 2009-2013[J]. PLoS One, 2014, 9(8)：e101347.
[6]
Gouzel K, Josette P, Agnes U, et al. A bacterial two-hybrid system based on a reconstituted signa transduction pathwayl[J]. Microbiology, 1998, 95(8)：5752-5756.
Sushant S, Rodney C, Thomas FW, et al. Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development[J]. Expert Review of Vaccines, 2013, 12(9)：1021-1031.
[9]
Sarika J, Tulsi DC. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi[J]. J Infect Dev Ctries 2013, 7(11)：788-795.
[10]
Roucourt B, Chibeu A, Lecoutere E, et al. Homotypic interactions among bacteriophage φKMV early proteins[J]. Archives of virology, 2007, 152：1467-1475.
[11]
Capparelli R, Nunzia N, Marco I, et al. Bacteriophage therapy of Salmonella enterica：a fresh appraisal of bacteriophage therapy[J]. J Infect Dis, 2010, 201(1)：52-61.
